This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Y. Articles by Reynolds, C. P. Search for Related Content PubMed PubMed Citation Articles by Wang, Y. Articles by Reynolds, C. P.

Expression of Protein Gene Product 9.5 and Tyrosine Hydroxylase in Childhood Small Round Cell Tumors¹

Division of Hematology-Oncology, Childrens Hospital Los Angeles, Los Angeles, California 90027 [Y. W., P. E., R. C. S., C. P. R.], and Departments of Pediatrics [R. C. S., C. P. R.] and Pathology [Y. W., T. J. T., C. P. R.], University of Southern California School of Medicine, Los Angeles, California 90033

Small round cell tumors of childhood can be histologically ambiguous, can require tumor markers for an accurate diagnosis, and include neuroblastoma, peripheral primitive neuroectodermal tumor (pPNET), Ewing’s sarcoma (ES), lymphoma, and rhabdomyosarcoma. Because the cell type of origin for ES remains controversial, characterizing gene expression in ES can provide diagnostic markers and lead to better understanding of tumor biology. We studied RNA expression of the neuronal genes protein gene product 9.5 (PGP 9.5) and tyrosine hydroxylase (TH) by Northern analysis in cell lines and tissue from small round cell tumors. PGP 9.5 showed strong expression in 17 of 17 neuroblastoma cell lines, 9 of 9 pPNET cell lines, and 11 of 11 ES cell lines. PGP 9.5 was weakly expressed in 1 of 1 alveolar rhabdomyosarcoma cell lines but not in 1 of 1 embryonal rhabdomyosarcomas, and weak expression was seen in 1 of 7 leukemia cell lines. In tumor tissue, all 12 neuroblastomas expressed PGP 9.5, as did all 7 pPNET and all 7 ES. PGP 9.5 was very weakly expressed in 6 of 9 rhabdomyosarcomas and 1 of 9 lymphomas. TH was expressed only in neuroblastomas, and no TH expression was seen in cell lines or tissue from other tumors. As high expression of PGP 9.5 was only found in neural tumors; PGP 9.5 expression by ES provides further evidence for a neural origin of this tumor, whereas TH expression is highly specific for neuroblastomas. PGP 9.5 expression should allow sensitive detection of minimal residual disease for ES and pPNET using reverse transcription-PCR, and the variability in TH and PGP 9.5 expression levels in neuroblastomas indicates that expression of both genes should be used for monitoring minimal residual disease by reverse transcription-PCR.

This article has been cited by other articles:

				J. A. Ramos-Vara and M. A. Miller Immunohistochemical Detection of Protein Gene Product 9.5 (PGP 9.5) in Canine Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides) Vet. Pathol., January 1, 2007; 44(1): 74 - 79. [Abstract] [Full Text] [PDF]

				S. Batra, C. P. Reynolds, and B. J. Maurer Fenretinide Cytotoxicity for Ewing's Sarcoma and Primitive Neuroectodermal Tumor Cell Lines Is Decreased by Hypoxia and Synergistically Enhanced by Ceramide Modulators Cancer Res., August 1, 2004; 64(15): 5415 - 5424. [Abstract] [Full Text] [PDF]

				J. Sugimura, R. S. Foster, O. W. Cummings, E. J. Kort, M. Takahashi, T. T. Lavery, K. A. Furge, L. H. Einhorn, and B. T. Teh Gene Expression Profiling of Early- and Late-Relapse Nonseminomatous Germ Cell Tumor and Primitive Neuroectodermal Tumor of the Testis Clin. Cancer Res., April 1, 2004; 10(7): 2368 - 2378. [Abstract] [Full Text] [PDF]

				S. Carlin, R. J. Mairs, A. G. McCluskey, D. A. Tweddle, A. Sprigg, C. Estlin, J. Board, R. E. George, C. Ellershaw, A. D. J. Pearson, et al. Development of a Real-Time Polymerase Chain Reaction Assay for Prediction of the Uptake of Meta-[131I]iodobenzylguanidine by Neuroblastoma Tumors Clin. Cancer Res., August 1, 2003; 9(9): 3338 - 3344. [Abstract] [Full Text] [PDF]

				C. Trager, P. Kogner, M. Lindskog, F. Ponthan, A. Kullman, and B. Kagedal Quantitative Analysis of Tyrosine Hydroxylase mRNA for Sensitive Detection of Neuroblastoma Cells in Blood and Bone Marrow Clin. Chem., January 1, 2003; 49(1): 104 - 112. [Abstract] [Full Text] [PDF]

				N. Keshelava, J. J. Zuo, P. Chen, S. N. Waidyaratne, M. C. Luna, C. J. Gomer, T. J. Triche, and C. P. Reynolds Loss of p53 Function Confers High-Level Multidrug Resistance in Neuroblastoma Cell Lines Cancer Res., August 1, 2001; 61(16): 6185 - 6193. [Abstract] [Full Text] [PDF]

				D. S. B. Hoon, C. T. Kuo, S. Wen, H. Wang, L. Metelitsa, C. P. Reynolds, and R. C. Seeger Ganglioside GM2/GD2 Synthetase mRNA Is a Marker for Detection of Infrequent Neuroblastoma Cells in Bone Marrow Am. J. Pathol., August 1, 2001; 159(2): 493 - 500. [Abstract] [Full Text]